Ladenburg Thalmann Financial Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$32.9M Sell
890,961
-22,837
-2% -$813K 0.21% 110
2019
Q3
$31.2M Buy
913,798
+9,982
+1% +$363K 0.21% 114
2019
Q2
$37.2M Sell
903,816
-12,272
-1% -$487K 0.27% 76
2019
Q1
$36.9M Buy
916,088
+44,860
+5% +$1.8M 0.28% 71
2018
Q4
$36M Buy
871,228
+84,052
+11% +$3.49M 0.32% 65
2018
Q3
$32.9M Buy
787,176
+48,795
+7% +$1.88M 0.28% 84
2018
Q2
$24.8M Hold
738,381
0.23% 103
2018
Q1
$24.8M Buy
738,381
+39,696
+6% +$1.36M 0.23% 103
2017
Q4
$24M Buy
698,685
+48,087
+7% +$1.64M 0.23% 103
2017
Q3
$22.1M Buy
650,598
+6,758
+1% +$217K 0.24% 101
2017
Q2
$20.5M Sell
643,840
-13,370
-2% -$422K 0.24% 97
2017
Q1
$21.3M Sell
657,210
-29,903
-4% -$943K 0.27% 77
2016
Q4
$21.2M Buy
687,113
+7,199
+1% +$220K 0.3% 69
2016
Q3
$21.8M Buy
679,914
+41,202
+6% +$1.38M 0.33% 64
2016
Q2
$21.3M Buy
638,712
+42,845
+7% +$1.37M 0.34% 66
2016
Q1
$16.8M Buy
595,867
+11,390
+2% +$325K 0.3% 77
2015
Q4
$17.9M Buy
584,477
+3,963
+0.7% +$125K 0.33% 65
2015
Q3
$17.3M Sell
580,514
-35,206
-6% -$1.13M 0.36% 64
2015
Q2
$19.6M Buy
615,720
+29,441
+5% +$960K 0.36% 62
2015
Q1
$19.3M Buy
586,279
+87,482
+18% +$2.78M 0.37% 57
2014
Q4
$14.8M Buy
498,797
+108,650
+28% +$3.12M 0.33% 65
2014
Q3
$10.9M Buy
390,147
+13,470
+4% +$378K 0.3% 76
2014
Q2
$10.6M Buy
376,677
+22,907
+6% +$653K 0.29% 82
2014
Q1
$10.8M Buy
353,770
+2,735
+0.8% +$81.5K 0.31% 73
2013
Q4
$10.2M Sell
351,035
-27,356
-7% -$796K 0.31% 72
2013
Q3
$10.3M Sell
378,391
-3,124
-0.8% -$85K 0.35% 66
2013
Q2
$10.1M Buy
+381,515
New +$10.5M 0.36% 63

Other funds holding PFE

Ladenburg Thalmann Financial Services's PFE Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its Pfizer (PFE) stake by 2.5% in Q4 2019, selling an estimated $813K and leaving 890,961 shares worth $32.9M. The position accounts for 0.21% of the portfolio, ranked #110.

Ladenburg Thalmann Financial Services first reported a position in PFE in Q2 2013 and has held it in 27 quarters since. The position peaked at $37.2M in Q2 2019. 2,524 funds tracked by Wall St. Rank hold PFE as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 890,961 shares of Pfizer worth $32.9M as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 22,837 Pfizer shares in Q4 2019, an estimated $813K.
  • Pfizer made up 0.21% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #110 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Pfizer in Q2 2013 and has held it in 27 quarters since.
  • Ladenburg Thalmann Financial Services's Pfizer position peaked at $37.2M in Q2 2019.
  • 2,524 funds tracked by Wall St. Rank held Pfizer as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.